XML 27 R18.htm IDEA: XBRL DOCUMENT v2.3.0.15
Related Party
9 Months Ended
Sep. 30, 2011
Related Party
13.
Related Party
 
In connection with our acquisition of Anika S.r.l. on December 30, 2009, Fidia Farmaceutici S.p.A. (“Fidia”) acquired ownership of 1,981,192 shares of the Company's common stock, of which 800,000 shares remain in escrow at September 30, 2011. As of September 30, 2011, Fidia owns approximately 14.5% of the outstanding shares of the Company.
 
                As part of the acquisition, the Company, primarily through Anika S.r.l., entered into a series of operating agreements with Fidia as follows:
 
Agreement Type
Description
Term in Years
Lease
Rent of space in Abano Terme, Italy
Six
Finished goods supply
Manufacture and supply of goods
Three
Raw material supply
Hyaluronic acid powder
Five
Accounts receivable management
Collection of trade receivables outstanding as of December 30, 2009
Two
Marketing and Promotion
Promote Anika S.r.l. products in Italy through Fidia sales force
Three
 
Historically, Anika S.r.l. has relied on Fidia, its former parent company, for several functional activities. In connection with the purchase of Anika S.r.l., the Company has negotiated a lease for approximately 26,000 square feet of office, laboratory and warehouse space in Abano Terme, Italy, and a finished goods supply agreement. In addition, accounting and purchasing services were performed by Fidia on behalf of Anika S.r.l. during 2010 under an agreement which ended with the completion of the accounting close for the year then ended. Finally, Fidia has agreed to promote Anika S.r.l.'s products in Italy through its existing sales force. At September 30, 2011, Anika S.r.l. had a net payable to Fidia for past products and services of approximately $1.2 million.